Scarica l'app Stockscreener
63.93
0.92%
0.58
Dopo l'orario di chiusura:
63.93
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Ani Pharmaceuticals Inc Borsa (ANIP) Ultime notizie
How does ANI Pharmaceuticals Inc. compare to its industry peersBuild wealth steadily with smart stock selection - jammulinksnews.com
What analysts say about ANI Pharmaceuticals Inc. stockMaximize gains with timely market signals - jammulinksnews.com
What is ANI Pharmaceuticals Inc. company’s growth strategyExplosive trading opportunities - jammulinksnews.com
What are the latest earnings results for ANI Pharmaceuticals Inc.High-profit trading signals - jammulinksnews.com
Is ANI Pharmaceuticals Inc. a good long term investmentBoost your wealth with consistent growth stocks - jammulinksnews.com
How many analysts rate ANI Pharmaceuticals Inc. as a “Buy”Get professional guidance for market timing - jammulinksnews.com
What drives ANI Pharmaceuticals Inc. stock priceUnlock daily trading alerts for profits - jammulinksnews.com
What is the dividend policy of ANI Pharmaceuticals Inc. stockRealize consistent double-digit growth - jammulinksnews.com
How volatile is ANI Pharmaceuticals Inc. stock compared to the marketConsistent wealth multiplication - jammulinksnews.com
ANI Pharmaceuticals Inc. Stock Analysis and ForecastUnlock steady growth with low-risk stocks - jammulinksnews.com
Should I hold or sell ANI Pharmaceuticals Inc. stock in 2025Exceptional profit potential - jammulinksnews.com
What makes ANI Pharmaceuticals Inc. stock price move sharplyAccelerate your capital gains today - jammulinksnews.com
Is ANI Pharmaceuticals Inc. stock overvalued or undervaluedCapitalize on market momentum for maximum profit - jammulinksnews.com
ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET - GlobeNewswire
How strong is ANI Pharmaceuticals Inc. company’s balance sheetEntry Signal Tracker For Consistent Profits - jammulinksnews.com
ANI Pharmaceuticals Sets Q2 2025 Earnings Call Date: Key Executive Team to Present Financial Results - Stock Titan
What are ANI Pharmaceuticals Inc. company’s key revenue driversAdvanced Screener Planner For Consistent Profits - jammulinksnews.com
Lacklustre Performance Is Driving ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Low P/S - 富途牛牛
ANI Pharmaceuticals (NASDAQ:ANIP) shareholders are still up 107% over 5 years despite pulling back 4.3% in the past week - simplywall.st
ANI Pharmaceuticals (NASDAQ:ANIP) pulls back 4.3% this week, but still delivers shareholders strong 16% CAGR over 5 years - Yahoo.co
Does ANI Pharmaceuticals Inc. stock perform well during market downturnsEntry Signal Guidance With Proven Results - jammulinksnews.com
Real time scanner hits for ANI Pharmaceuticals Inc. explainedSmart Allocation Stock Pick Insights Gaining Interest - metal.it
ANI Pharmaceuticals Challenges Court Verdict on Royalty Payment Agreement - AInvest
ANI Pharmaceuticals to Challenge Court Verdict - The Globe and Mail
Can ANI Pharmaceuticals Inc. Rally Enough to Break EvenTrend Analysis for Safer Trades Gains Popularity - metal.it
Is ANI Pharmaceuticals Inc. stock poised for growthFast Gaining Stock Screener Reports Released - metal.it
Short Covering May Lift ANI Pharmaceuticals Inc. in Near TermSmart Trade Plans With Risk Protection Explained - metal.it
Why ANI Pharmaceuticals Inc. stock attracts strong analyst attentionTriple Digit Return Forecasts - beatles.ru
CG Oncology wins Delaware jury trial against ANI Pharmaceuticals By Investing.com - Investing.com South Africa
CG Oncology wins Delaware jury trial against ANI Pharmaceuticals - Investing.com Australia
Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals - The Manila Times
CG Oncology Secures Major Legal Victory: Court Rules No 5% Royalties on Promising Bladder Cancer Drug - Stock Titan
Published on: 2025-07-29 19:34:49 - metal.it
Is ANI Pharmaceuticals (ANIP) a High-Probability Earnings Beat Candidate in Q2 2025? - AInvest
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Q2 Release - Yahoo Finance
Published on: 2025-07-29 03:23:31 - metal.it
ANI Pharmaceuticals: Classic Case Of Capital Intensive Growth Hampering Value (NASDAQ:ANIP) - Seeking Alpha
How does ANI Pharmaceuticals Inc. generate profit in a changing economySkyrocketing returns - jammulinksnews.com
Is ANI Pharmaceuticals Inc. a growth stock or a value stockPhenomenal capital gains - jammulinksnews.com
0.87%
0.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):